Every Form 4 that Precision Optics Corporation, Inc. (POCI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow POCI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full POCI filings page.
PRECISION OPTICS CORPORATION, INC. (POCI) reported that Senior VP - Sales & Marketing Peter Richard Thier received a grant of stock options on August 18, 2026. The grant covers 50,000 options to buy common stock at an exercise price of $4.34 per share, expiring August 17, 2036. According to the disclosure, this inducement stock option vests in three equal annual installments beginning on August 18, 2027, and results in direct beneficial ownership of options on 50,000 shares.
Precision Optics Corporation, Inc. reported that Chief Financial Officer Wayne M. Coll acquired 1,257 shares of common stock on June 30, 2026, at $4.972 per share as a grant/award. This stock issuance reflects an Employment Agreement allowing up to $25,000 per year of compensation to be paid in stock instead of cash, priced at the quarterly volume weighted average price. Following this transaction, Coll directly holds 38,064 shares of common stock. The shares dated June 30, 2026 were issued on August 12, 2026 based on payroll withholdings for the relevant quarters.
COLL WAYNE M reported acquisition or exercise transactions in this Form 4 filing.
PRECISION OPTICS CORPORATION, INC. Chief Financial Officer Wayne M. Coll received a grant of 1,568 shares of common stock on March 31, 2026 as compensation. The shares were issued under an Employment Agreement that allows up to $25,000 per year of salary to be paid in stock.
The stock was priced at a quarterly volume weighted average price of $3.985 for the quarter ended March 31, 2026, based on payroll withholdings. After this grant, Coll directly owns 36,807 shares of Precision Optics common stock.
PRECISION OPTICS CORPORATION, INC. Chief Financial Officer Wayne M. Coll reported an open-market purchase of the company’s Common Stock. On March 30, 2026, he bought 20,833 shares at a price of $3.60 per share in an underwritten public offering. Following this transaction, he directly owns 35,239 shares of Precision Optics common stock.
Precision Optics Corporation, Inc. CEO Joseph Norman Forkey bought 1,388 shares of common stock in an open-market purchase. The transaction was completed at $3.60 per share in connection with an underwritten public offering. Following this purchase, he directly holds 143,959 common shares.
PRECISION OPTICS CORPORATION, INC. Chief Operating Officer Joseph Traut bought 41,666 shares of Common Stock at $3.60 per share in an underwritten public offering. This open-market purchase increased his directly held stake to 41,666 shares.
The transaction was reported as a standard open-market purchase, with each share acquired at the public offering price set for the underwritten deal.
Precision Optics Corporation director Andrew J. Miclot exercised stock options for 20,000 shares of Common Stock at an exercise price of $1.44 per share on March 12, 2026. To cover tax obligations, 6,372 shares were withheld at $4.52 per share, leaving him with 13,628 shares of Common Stock held directly after the transactions.
Precision Optics Corporation, Inc. (POCI) reported a new equity award to a director on a Form 4. The filing shows a grant of stock options to purchase 30,000 shares of common stock at an exercise price of $4.33 per share on 11/17/2025, reported as an acquisition of derivative securities held directly.
The options expire on 11/17/2035 and were granted under the company’s 2022 Equity Incentive Plan. They vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, conditioned on the director’s continuous service with the company through each applicable vesting date.
Precision Optics Corporation, Inc. (POCI) reported that one of its directors received a grant of 30,000 stock options on 11/17/2025. The options have an exercise price of $4.33 per share and are exercisable for an equal number of shares of common stock, with an expiration date of 11/17/2035. They were granted under the company’s 2022 Equity Incentive Plan.
The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains in continuous employment with Precision Optics through each vesting date. Following this grant, the director holds 30,000 derivative securities directly.
Precision Optics Corporation, Inc. (POCI) reported an insider equity award for a director. The filing shows a grant of stock options, which are rights to buy common stock in the future at a fixed price.
The director received 30,000 stock options with an exercise price of $4.33 per share, becoming exercisable over time. According to the filing, these options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains in continuous employment with the company through each vesting date. The options were granted under the company’s 2022 Equity Incentive Plan and are scheduled to expire on November 17, 2035.
Precision Optics Corporation, Inc. (POCI) reported an equity award to one of its directors. On 11/17/2025, the director received stock options giving the right to buy 30,000 shares of POCI common stock at an exercise price of $4.33 per share. These options expire on 11/17/2035 and were granted under the company’s 2022 Equity Incentive Plan.
The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, as long as the director remains continuously employed by the company through each applicable vesting date.
Precision Optics Corporation (POCI) disclosed a Form 4 showing an inducement stock option grant to its Chief Operating Officer. On October 1, 2025, the executive received options to purchase 60,000 shares of common stock at an exercise price of $4.34 per share.
The option vests in three equal annual installments beginning October 1, 2026, and expires on October 1, 2035. Following the grant, the reporting person beneficially owns 60,000 derivative securities, held directly.